Picture of Ajanta Pharma logo

AJANTPHARM — Ajanta Pharma News Story

0.000.00%
in flag iconLast trade - 00:00
HealthcareBalancedLarge CapHigh Flyer

Brief: Ajanta Pharma's Dahej facility does not get form 483 after FDA inspection

April 10 (Reuters) - Ajanta Pharma Ltd  AJPH.NS  
    * Ajanta Pharma Ltd says co's Dahej facility was inspected 
by FDA from April 3-7, 2017; no form 483 was issued 
 
Source text:  
[This is to inform you that Company's formulation facility at 
Dahej was 
inspected by US FDA from 3rd to 7th April, 2017.   At the end of 
the 
inspection, no Form 483 was issued to the Company] 
Further company coverage:  AJPH.NS  
 
 ((Bangalore.newsroom@thomsonreuters.com;))

Recent news on Ajanta Pharma

See all news